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ABSTRACT 
Obesity is the most prevalent nutritional disease and a growing public health problem worldwide. This disease is 
a causal component of the metabolic syndrome related with abnormalities, including hyperglycemia, dyslipidem-
ia, hypertension, inflammation, among others. There are anti-obesity drugs, affecting the fundamental processes 
of the weight regulation; however they have shown serious side effects, which outweigh their beneficial effects. 
Most recent studies on the treatment of obesity and its complications have focused on the potential role of differ-
ent plants preparation that can exert a positive effect on the mechanisms involved in this pathology. For instance, 
anti-obesity effects of green tea and its isolated active principles have been reported in both in vitro (cell cul-
tures) and in vivo (animal models) that possess healthy effects, decreasing adipose tissue through reduction of 
adipocytes differentiation and proliferation. A positive effect in lipid profile, and lipid and carbohydrates metab-
olisms were demonstrated as well. In addition, anti-inflammatory and antioxidant activities were stud-
ied. However, the consumption of green tea and its products is not that common in Western countries, where 
other plants with similar bioactivity predominate; nevertheless, the effect extension has not been analyzed in 
depth, despite of their potential as alternative treatment for obesity. In this review the anti-obesity potential and 
reported mechanisms of action of diverse plants such as: Camellia sinensis, Hibiscus sabdariffa, Hypericum per-
foratum, Persea americana, Phaseolus vulgaris, Capsicum annuum, Rosmarinus officinalis, Ilex paraguariensis, 
Citrus paradisi, Citrus limon, Punica granatum, Aloe vera, Taraxacum officinale and Arachis hypogaea is sum-
marized. We consider the potential of these plants as natural alternative treatments of some metabolic alterations 
associated with obesity. 
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INTRODUCTION 
Obesity is now the most prevalent nutri-
tional disease and a growing public health 
problem worldwide. The disease has ac-
quired epidemic proportions projected to 
reach 2.3 billion of overweight adults and 
700 million obese adults, respectively by 
2015 (Malik et al., 2013). 
Overweight is an established risk factor 
for type 2 diabetes and cardiovascular dis-
eases, where the central and causal compo-
nent is the metabolic syndrome (Montague 
and O’Rahilly, 2000). This is a series of 
metabolic abnormalities including hypergly-
cemia, dyslipidemia, hypertension, inflam-
mation, oxidative stress, among others 
(Grundy et al., 2004).  
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Perturbed intravascular lipid and lipopro-
tein metabolism is a common feature of obe-
sity, leading to a dyslipidemia involving ele-
vated plasma concentrations of triglycerides 
and apolipoprotein (apo) B-containing lipo-
proteins (very low density lipoprotein: 
VLDL and low density lipoprotein: LDL) 
and subnormal levels of high density lipo-
protein: HDL), a lipid phenotype associated 
with accelerated atherosclerosis and high 
cardiovascular risk (Ståhlman et al., 2013).  
The metabolic syndrome consequence of 
obesity is associated in part by the alterations 
in adipose tissue; however, it is not the only 
one involved, participating other tissues such 
as liver, among others (Hirosumi et al., 
2002). Adipocytes produce a variety of bio-
logically active molecules (Saltiel and Kahn, 
2001) collectively known as adipocytokines 
or adipokines (e.g. Tumor necrosis factor 
alpha: TNFα and interleukin-6: IL6). In obe-
sity, hypertrophy of adipocytes could lead to 
regions of hypoxia, which could instigate an 
inflammatory response (Ye et al., 2007). 
This phenomenon could alter the adipokine 
profile via reduced adiponectin expression 
(Wree et al., 2012) and increased leptin 
(Skurk et al., 2007). Increased TNF-α and 
IL-6 production by adipose tissue infiltrated-
macrophages were associated with athero-
genic effects and insulin resistance (Mracek 
et al., 2010; Skurk et al., 2007).  
Insulin resistance is one of the most 
common alterations on obesity (Boden, 
2011), and is closely linked with diseases 
such as type 2 diabetes, fatty liver, athero-
sclerosis, hypertension, among others (Bray, 
2004). The alterations on insulin metabolism 
involve glucose transport, glycogen synthe-
sis, and changes on lypolisis (Boden, 2011).  
There are different pharmacological 
treatments; for example, Orlistat (Xenical), 
which reduces intestinal fat absorption 
through inhibition of pancreatic lipase 
(Thurairajah et al., 2005), and Sibutramine 
(Reductil) that is an appetite suppressant 
(Tziomalos et al., 2009). Furthermore, the 
consumption of anti-obesity drugs provokes 
collateral effects such as alterations in blood 
pressure, headaches, among others (de 
Simone and D’Addeo, 2008; Karamadoukis 
et al., 2009; Slovacek et al., 2008; Thuraira-
jah et al., 2005).  
Most recent studies on the treatment of 
obesity have focused on the potential role of 
plants used for obesity and its metabolic dis-
orders treatments, exerting a positive effect 
on lipid and glucose metabolism, and anti-
inflammatory activity. For instance, anti-
obesity effects of green tea; its bioactive 
compounds have demonstrated in both in 
vitro (cell cultures) and in vivo (animal mod-
els) that possess a healthy effect, decreasing 
adipose tissue through reduction of adipo-
cytes differentiation and proliferation. A pos-
itive effect in lipid profile, and lipid and car-
bohydrates metabolisms, and anti-inflamma-
tory activities were observed as well (Tipoe 
et al., 2007; Wolfram et al., 2006). However, 
the consumption of green tea in Western 
countries is not that common as other plants 
with similar effects. For this reason and due 
to the huge worldwide public health problem 
that obesity represents, we have summarized 
the information on some traditional plants 
with anti-obesity potential based in the cur-
rent scientific literature. 
 
EPIDEMIOLOGY OF OBESITY 
Obesity is a clinical condition, whose 
prevalence has sharply increased in the last 
decades in Western countries and, later on, 
worldwide. Obesity has been defined as a 
pandemic and one of the major health prob-
lems ever. 
The prevalence of overweight in children 
is greater than 25 %, whereas in adults, it is 
greater than 50 % (Barquera et al., 2013a). In 
Mexico the incidence of obesity has been 
increased in the past 30 years, where the fe-
male population has been the most affected 
group (approximate 1.5 % points); while, the 
preschool children have shown lower mor-
bidity (0.3 % points) (Barquera et al., 
2013b). This prevalence is associated with 
the extreme dietary changes occurred in 
Western countries such as Mexico, which 
may be summarized as an increase in con-
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sumption of non-nutritional carbohydrates, 
especially sugar-sweetened beverages that 
has led to an increasing rate of chronic dis-
eases related to obesity such as diabetes and 
cardiovascular diseases. 
 
Pathophysiology of obesity: adipose tissue 
Human adipose tissue is divided into 
brown and white adipose tissues. The main 
activity of brown adipocytes is the regulation 
of thermogenesis. This is due to brown adi-
pocytes cells that have numerous mitochon-
dria; therefore, they express high concentra-
tion of uncoupling protein 1 (UCP-1) 
(Dulloo et al., 2010). On the other hand, adi-
pocytes are responsible for fat storage. The 
structure of adipose tissue includes macro-
phages, fibroblasts, pre and mature adipo-
cytes (Sánchez et al., 2005).  
High caloric diet promotes hyperplasia 
and hypertrophy of adipocytes. When a hy-
pertrophy occurs, the size of adipocytes in-
creases and the diffusion of oxygen is affect-
ed leading to hypoxia (Poulain-Godefroy et 
al., 2008). As a result of hypoxia, adipocytes 
express the factor hypoxia-inducible (HIF-
1a) and the unfolded protein response in the 
endoplasmic reticulum (Goossens, 2008). 
HIF-1a modulates the genes involved with 
the expression of pro-inflammatory cyto-
kines, for example: leptin, vascular endothe-
lial growth factor (VEGF), among others 
(Goossens, 2008). Other feature of hyper-
trophic adipocytes is that they show poor 
sensibility to insulin, due to the reported af-
fectation of membrane receptors as conse-
quence of obesity. This contributes to in-
flammation through diapedisis of monocytes 
to visceral stroma (Deng and Scherer, 2010).  
The lower insulin sensitivity in hyper-
trophic adipocytes, is related in part to the 
non-esterified fatty acids, glycerol, hor-
mones, and other factors released by these 
cells. The association of alterations in pan-
creatic islet β-cells and insulin resistance in 
insulin-dependent tissues lead to type 2 dia-
betes (Kahn et al., 2006). 
 
Obesity and its complications:  
inflammation, diabetes type 2, and  
cardiovascular disease 
There are multiple molecular mecha-
nisms linking obesity to its complications 
such as type 2 diabetes mellitus, hyperten-
sion, hypercholesterolemia, atherosclerosis, 
non-alcoholic fatty liver disease, among oth-
ers. However, inflammation is a common 
feature that has been implicated in the patho-
physiology of many obesity-associated dis-
orders. For instance, the main biological ef-
fect of leptin is the control of adipose tissue 
growth via its central nervous system action 
(Berglund et al., 2012). In obesity there are 
increased levels of leptin, resulting in an ap-
parent decrease of its anorexigenic effects 
and weight loss, result of a mechanism of 
resistance to it (Fonseca-Alaniz et al., 2007). 
Leptin acts directly on macrophages increas-
ing phagocytic activity and pro-inflamma-
tory cytokine production. Leptin also stimu-
lates proliferation and migration of endothe-
lial cells and smooth muscle cells, thus fa-
voring the development of atherosclerosis 
(Cachofeiro et al., 2006). 
Another example of the relation of disor-
ders of obesity and inflammation is interleu-
kin 6 (IL-6). This molecule is associated 
with the regulation of insulin signaling, de-
creasing the expression of the insulin recep-
tor substrate 1 (IRS1), and upregulating the 
expression of suppressor of cytokine signal-
ing (SOCS-3) (Rieusset et al., 2004). SOCS-
3 belongs to a family of inflammatory medi-
ators that contributes to obesity-induced in-
sulin resistance, which constitutes a negative 
feedback pathway in cytokine signaling (Lu-
bis et al., 2008). 
The definition of insulin resistance im-
plies a lower sensitivity to insulin by cells 
and alterations on glucose metabolism (for 
example: uptake or storage). In obesity and 
type 2 diabetes a decrease in insulin-
stimulated glucose transport is observed; in 
addition, alterations on metabolism of adipo-
cytes, skeletal muscle, and hepatic glucose 
output are also reported (Reaven, 1995). 
Even though, insulin resistance is closely 
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associated with several chronic diseases such 
as atherosclerosis, hyperlipidemia, and hy-
pertension, among others (Reaven, 1995; 
Meigs et al., 2007). 
The metabolic insulin resistance is usual-
ly accompanied by compensatory hyperinsu-
linemia, which may stimulate unaffected 
MAPK-dependent pathways in the vascula-
ture, leading to decreased production of ox-
ide nitric (NO) and increased secretion of 
endoteline 1 (ET-1) (Eringa et al., 2004; 
Mather et al., 2004). As a consequence, vas-
oconstriction of resistance arteries and ter-
minal arterioles occurs, causing impaired 
regulation of muscle perfusion, glucose up-
take, and blood pressure (Levy et al., 2001), 
resulting in cardiovascular disorders. 
 
Plants used as an alternative for obesity 
and its complications 
The complex pathogenesis of obesity in-
dicates the need of different intervention 
strategies to confront this problem. Herbal 
supplements and diet-based therapies for 
weight loss are among the most common 
complementary and alternative medicine 
modalities (Barnes et al., 2002). As an alter-
native treatment of obesity and its complica-
tions, in the market are a variety of natural 
products that includes medicinal plants, ei-
ther as pure compounds or as extracts 
(Hasani-Ranjbar et al., 2013). 
Different plants contain a large variety of 
several components with different anti-
obesity effects on body metabolism and fat 
oxidation, and for this reason have been in-
vestigated and reported to be useful in treat-
ment of obesity, diabetes and other chronic 
diseases (Hasani-Ranjbar et al., 2009, 2010). 
 
Camellia sinensis 
The most studied plant due to its wide 
range of effects including anti-obesity and 
antioxidant properties is Camellia sinensis. 
Various studies have shown its beneficial 
effects on obesity. For example, Tian et al. 
(2013) reported that a treatment with tea 
phytochemicals (0.8, 1.6, 3.2 g/L) adminis-
tered as drinking water to male Wistar rats 
fed with high-fat diet for 26 weeks attenuat-
ed visceral adipose tissue accumulation (ap-
prox. 40 % at all doses). Similarly, green tea 
extract (400 mg/kg body weight/day) admin-
istered concomitantly in obese mice induced 
with high-fat diet for 8 weeks, increased the 
hormone-sensitive lipase and perilipin in 
mesenteric adipose tissue (Cunha et al., 
2013). This was associated to reduced body 
weight (16 %) and adipose tissue gain (64 % 
on epididymal adipose tissue) compared with 
the obese control.  
A recent study showed that not only the 
leaf of C. sinensis has anti-obesity effect, but 
also the fruit peel, which is considered an 
agricultural waste (Chaudhary et al., 2014). 
The administration of ethanolic green tea 
fruit peel extract (100 mg/kg/d) on high-fat 
diet feed female Sprague–Dawley rats for 50 
days significantly decreased the body weight 
(approx. 25 %) and white adipose tissue fat-
pad weights (74 %) than the obese control.  
Different anti-obesity acting mechanisms 
have been reported for C. sinensis, including 
inhibition of pancreatic lipase (Grove et al., 
2012; Yuda et al., 2012), appetite-repression 
activity (Moon et al., 2007; Wolfram et al., 
2006), adipogenesis down-regulation (Lu et 
al., 2012), thermogenesis (Hursel et al., 
2011), lipid metabolism (Axling et al., 2012; 
Lu et al., 2012), among others. 
The chemical compounds with the pre-
sumed anti-obesity effect are especially cate-
chin type polyphenols. An in vivo animal 
model study reports that Epigallocatechin 3-
gallate, which is the major catechin like fla-
vonoid in Camellia sinensis reduces body 
weight gain (Bose et al., 2008). In human 
experiments, acute ingestion of green tea ex-
tracts increases the proportion of whole-body 
fat utilization by augmenting oxidation and 
lipolysis (Basu et al., 2010). 
An increasing number of studies have 
shown beneficial effects of green tea in met-
abolic disorders associated to obesity such as 
inflammation, metabolic syndrome, type-2 
diabetes and cardiovascular disease. For ex-
ample, Park et al. (2012) reported that green 
tea extract suppresses nuclear factor kappa-
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light-chain-enhancer of activated β cells 
(NFkβ) activation and inflammatory re-
sponses in diet-induced obese rats with non-
alcoholic steatohepatitis. These anti-
inflammatory activities of green tea extract 
were also accompanied by improvements in 
tissue glutathione status, mitigated the de-
velopment of non-alcoholic steatohepatitis in 
an NFkB-dependent manner by improving 
tissue redox status.  
On the other hand, Park et al. (2011) re-
ported that Camellia sinensis attenuates fat 
liver through decreased lipogenesis and im-
proved hepatic oxidative stress conditions in 
ob/ob mice. Also, treatment with green tea 
polyphenols administered to male fat Wistar 
rats decreased total cholesterol, LDL, and 
triglycerides serum concentrations than 
obese controls at any experimented doses 
(Tian et al., 2013). 
Due to all this evidence, research in 
depth of the different health properties of C. 
sinensis continues. Additionally, in order to 
understand the effects and mechanisms of 
action of others plant material with similar 
effects is common observed to C. sinensis as 
reference of anti-obesity alternative.  
 
Hibiscus sabdariffa 
This plant is the second most studied af-
ter green tea and commonly used as a local 
soft drink against inflammation, hyperten-
sion, and liver disorders. Previous reports 
showed that aqueous extract of Hibiscus 
sabdariffa calyces (120 mg/kg/day) for 60 
days decreases body weight gain (22 %) and 
liver steatosis in monosodium glutamate in-
duced obese mice (Alarcon-Aguilar et al., 
2007). Similarly, Gamboa-Gómez et al. 
(2014) reported that infusions (1 % w/w) of 
H. sabadariffa (ad lib.) for 16 weeks in diet-
induced obese rats decreased body (10 %) 
and adipose tissue weights (29 %) compared 
with the obese controls.  
In clinical trials, an anti-obesity effect of 
H. sabadriffa was also reported. The con-
sumption for 12 weeks of H. sabdariffa ex-
tract reduced body weight, BMI, body fat 
and the waist-to-hip ratio in subjects with a 
BMI ≧ 27 and aged 18–65 (Chang et al., 
2014). 
Several anti-obesity acting mechanisms 
were reported for H. sabdariffa included the 
down-regulation of genes involved in lipid 
metabolism such as free fatty acid synthase 
(FAS) and Sterol Regulatory Element-
Binding Proteins (SREBP1c) (Gamboa-
Gómez et al., 2014). Additionally, Kim et al. 
(2003) reported that consumption of H. 
sabdariffa attenuates the hypertrophy of adi-
pocytes through the inhibition of lipid drop-
let accumulation; this is in association to the 
inhibition of adipocyte differentiation. Also, 
a down-regulation of pancreatic lipases and 
fatty acid synthases have been reported (Kim 
et al., 2003).  
The main phytochemicals with biological 
effect reported in H. sabdariffa are phenolic 
and flavonoids compounds with estimated 
contents of 58.80 and 13.57 mg/g dried 
flower, respectively; whereas, delphinidin-3-
sambubioside, cyanidin-3-sambubioside, 
kaempferol-3-glucoside, protocatechuic acid, 
and chlorogenic acid are included in its 
chemical composition (Peng et al., 2011). 
In addition to its anti-obesity activity, 
several studies have reported beneficial ef-
fect on complications associated to obesity. 
Low and high doses (100 and 200 mg/kg) of 
methanolic H. sabdariffa extracts in type 2 
diabetic rat model for 2 weeks improved 
blood glucose (52 and 57 % less, respective-
ly), ameliorating insulin resistance (Peng et 
al., 2011). It has also reduced serum triglyc-
erides (approx. 12 %), total cholesterol (10 
and 15 %, respectively), and the risk ratio of 
LDL/HDL (approx. 15 and 38 % less, re-
spectively). In addition to its antioxidative 
effect, H. sabdariffa suppressed the for-
mation of advanced glycation end product 
receptor (approx. 38 % less) and connective 
tissue growth factor which could be patho-
genic biomarkers in type 2 diabetes-
associated vasculopathy (Peng et al., 2011). 
On the other hand, Ali et al. (2014) re-
ported that treatment with H. sabdariffa ex-
tracts (rats dose: 125 or 60 mg/kg; human 
dose: 125 mg/kg/day) on spontaneously hy-
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pertensive rats (for one week) and patients 
diagnosed with metabolic syndrome (for four 
weeks) significantly reduced blood pressure 
after the intervention period in the form of 
24-h systolic blood pressure. In addition, H. 
sabdariffa extracts significantly reduced the 
amount of TNF-α-induced NFkβ and the re-
active oxygen species production. Also, they 
observed that H. sabdariffa extract (40 
g/mL) in humans, up-regulate the expression 
of oxide nitric synthase (eNOS), and there-
fore a higher concentration of oxide nitric 
was observed. 
This body of evidence interpreted togeth-
er, suggests that H. sabdariffa has great po-
tential to reduce not only obesity, but also 
diseases associated with cardiovascular dis-
ease. For this reason, further studies are sug-
gested. 
 
Hypericum perforatum 
St John’s wort (Hypericum perforatum 
L.) is an herbaceous perennial plant, native 
to Europe and Asia, and later introduced into 
America, where it has been naturalized. H. 
perforatum is traditionally used for its health 
benefits associated to its sedative potential in 
alterations such as depression, anxiety, and 
neuralgia, among others (Newall et al., 
1996). Several studies report that H. perfora-
tum has anti-obesity activity. For example, at 
100 and 200 mg/kg of H. perforatum orally 
administered as suspension in 0.3 % carbox-
ymethyl cellulose for 15 days in high-fat-fed 
rats reduced body weight (approx. 12 and 
15 %, respectively) compared with controls 
(Husain et al., 2011). Similarly, Hernández-
Saavedra et al. (2013a) demonstrated that 
body weight gain was prevented (8 %) in 
obese rats fed with fructose and high saturat-
ed fat diet by H. perforatum infusion (ad 
lib.) treatment for 12 weeks; in addition, a 
significant reduction of adipocyte volume 
(62 %), and fat content (28 %) than obese 
controls was observed. 
One anti-obesity acting mechanism re-
ported for H. perforatum is the quantity of 
serotonin present within synaptosomes and 
inhibiting the synaptosomal uptake of sero-
tonin (Husain et al., 2011; Muller, 1997). 
This increased level of serotonin reduces the 
food intake and suppresses the appetite 
(Yegorova and Jiang, 2002). 
Among the compounds with biological 
activity reported for H. perforatum are in-
cluded hyperforin, hypeicin, flavonoids 
(kaempferol, quercetin, luteolin, isoquer-
citrin, quercitrin, rutin, among others), and 
condensed tannins (proanthocyanidins) are 
also present (Nahrstedt and Butterweck, 
1997).  
Moreover, H. perforatum has shown ac-
tivity against complications associated to 
obesity. Husain et al. (2011) reported that H. 
perforatum hydroalcoholic extract (50 %) 
significantly inhibited the increase in plasma 
glucose (85 %) and insulin (89 %) caused by 
fructose feeding, and 200 mg/kg of this ex-
tract significantly decreased plasma glucose 
(29 %) and insulin (12 %) level compared to 
fructose-fed control group. In addition to 
these results, H. perforatum dose dependent-
ly and significantly decreased total choles-
terol (16 %) and triglycerides levels (18 %), 
while HDL (14 %) was increased compared 
to vehicle-treated fructose fed rats. 
Similarly, Hernández-Saavedra et al. 
(2013a) reported that treatment of H. perfo-
ratum infusion ameliorated hyperglycemia in 
obese rats maintaining glucose levels under 
100 mg/dL and insulin values similarly to 
the healthy control. Additionally, H. perfora-
tum treatment group had the lowest leptin 
(21 %) and TNF-α (43 %) values as well as a 
substantial increase in the adiponectin 
(67 %) concentration than the obese control. 
All this evidence is clearly relevant for 
assessing anti-obesity potential of H. perfo-
ratum, but it does not lend it all to establish-
ing effect in human. Therefore, clinical in-
vestigations are required. 
 
Persea americana 
Avocado (Persea americana) belongs to 
the laurel family Lauraceae and is native 
from Central and South America. Its cultiva-
tion has spread throughout Africa, Asia, Eu-
rope and United States. It has been reported 
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that avocado leaves are traditionally used as 
an alternative treatment for diseases such as 
hypertension, diarrhea, pyorrhea, hemor-
rhage, sore throat; whereas the fruit is con-
sumed as food (Brai et al., 2007). 
Anti-obesity effects have been reported 
for both the leaf and fruit. Brai et al. (2007) 
reported that treatment with aqueous and 
methanolic extracts of P. americana leaves 
(10 mg/Kg) for 8 weeks in hypercholester-
olemic albino rats (feed with diet containing 
20 % groundnut oil, 0.5 % cholesterol, and 
0.25 % cholic acid) caused 25 % reduction in 
the body weight gain compared to the con-
trol. 
Additionally, Naveh et al. (2002) studied 
defatted avocado pulp (100 g/Kg diet) in rats 
fed with cholesterol for 28 days. It was re-
ported that body weight gains decreased 
(26 %) in the avocado-fed groups compared 
with a cellulose control group; they conclud-
ed that the defatted avocado pulp affected 
food consumption. Other anti-obesity mech-
anism was studied by Padmanabhan and Ar-
umugam, (2014). They reported that hydro-
alcoholic fruit extract of P. americana (100 
mg/kg body weight) for 14 weeks, signifi-
cantly reduced the weight gain (24.77 %) 
and body mass index (17.92 %) in rats fed at 
high-fat diet (23 % fat). This effect was at-
tributed to the up-regulation of Peroxisome 
proliferator-activated receptor gamma 
(PPAR-γ).  
Few information of alternative mecha-
nism of action is available and this is an im-
portant area requiring additional data. Clini-
cal intervention trials should be conducted to 
verify the mechanisms of action of P. ameri-
cana observed in animal studies. 
Major chemical constituents of the plant 
parts from P. americana have been well 
summarized (Ding et al., 2007). These com-
pounds may be divided into alkanols (“ali-
phatic acetogenins”), terpenoid glycosides, 
various furan ring-containing derivatives, 
flavonoids, and a coumarin. The highly func-
tionalized alkanols of avocado have exhibit-
ed quite diverse biological properties thus far 
(Yasir et al., 2010).  
Several reports showed that P. america-
na had not only anti-obesity activity, but also 
positive action on metabolic related altera-
tions. For example, in alloxan-diabetic rats, 
the administration of a single dose of P. 
americana aqueous extract (100-200 mg/kg) 
improved the concentration of blood glucose 
after 12 h of experimentation (24, 22 and 
32 % less at 100, 150, and 200 mg/kg, re-
spectively). In addition, same extract doses 
produced a sustained significant antidiabetic 
activity during prolonged treatment (12 
days) (50, 58 and 60 % less on faster glucose 
levels, respectively) compared to the control 
group (Antia et al., 2005). 
Similar studies showed that aqueous and 
methanolic extracts from P. americana 
leaves (10 mg/kg of body weight) for 8 
weeks in albino rats with hypercholesterole-
mia (diet containing 20 % groundnut oil, 
0.5 % cholesterol, and 0.25 % cholic acid) 
improved blood glucose (16 and 11 %, re-
spectively) and lipid profile (total cholester-
ol: 8 and 5 %; LDL:19 and 20 % respective-
ly); this latter compared with hypercolester-
olemic control. Also, plasma HDL concen-
trations increased by 85 and 68 %, respec-
tively, compared to the hypercholesterolemic 
controls (Brai et al., 2007).  
Finally, in clinical trials, Ester et al. 
(2009) reported that the consumption of avo-
cado (30 cm3 of avocado-fat) by subjects 
with dyslipidemia as food for 30 
days, decreased triglycerides in serum 
(10.3 %) and increased HDL (6.3 %) com-
pared with baseline. However, the possible 
mechanism by which this effect is exerted 
has not been yet reported, and further studies 
are suggested. 
 
Phaseolus vulgaris 
Common beans (Phaseolus vulgaris L.) 
are considered an important source of protein 
in Latin-American countries. For this reason 
is an important grain legume that comprises 
50 % of consumption around the world 
(Broughton et al., 2003). 
Anti-obesity effect has been reported for 
this grain (Carai et al., 2011). Administration 
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in a multiple cycle of repeated treatments 
with a standardized P. vulgaris dry extracts 
(50 and 500 mg/kg) in three 5 day treatment 
periods followed by three 20 day off-
treatment periods, resulted in dose-
dependent decreases in daily food intake 
(approx. 17 % at 50 mg/kg dose and 33 % at 
500 mg/kg dose) and body weight (approx. 
40 % at both doses). 
In other recent study, Zhu et al. (2012) 
reported that consumption of common beans 
on mice decreased body weight through re-
duction of plasma leptin concentrations (Zhu 
et al., 2012). Although differences in final 
body weights between groups were not sta-
tistically significant. 
On clinical trials, Celleno et al. (2007) 
reported that dietary supplement containing 
445 mg of P. vulgaris extract, after 30 days 
of treatment, in subjects with a carbohydrate-
rich, 2000 to 2200-calorie diet, had signifi-
cant reductions of body weight (4 %), fat 
mass (10 %), and waist/hip circumferences 
(3/1.3 %, respectively) compared with the 
baseline. 
One of the anti-obesity mechanisms re-
ported for P. vulgaris relies on the reported 
α-amylase-inhibiting activity (Celleno et al., 
2007). On in vitro assays of P. vulgaris ex-
tracts inhibits activity of α-amylase which 
could be related with an interfered digestion 
of complex carbohydrates to simple absorb-
able sugars, potentially reducing carbohy-
drate-derived calories (Shamki et al., 2012). 
Another anti-obesity mechanism reported by 
Zhu et al. (2012) was the observed regulation 
of lipid biosynthesis in diet-induced obese 
C57BL/6J mice treated with cooked dry 
beans. Others authors, such as Carai et al. 
(2011) and Spadafranca et al. (2013) con-
cluded that the main anti-obesity activity is 
the inhibition of appetite improved the obesi-
ty conditions. 
P. vulgaris is an important source of pro-
tein, complex carbohydrates, minerals, and 
dietary fiber. Several bioactives compounds 
have been reported from common beans such 
as enzyme inhibitors, lectins, phytates, oligo-
saccharides, and polyphenols. These com-
pounds may play a key role in human me-
tabolism (Díaz-Batalla et al., 2006). Some 
phenolic compounds previously identified in 
P. vulgaris with biological activity are: quer-
cetin, kaempferol, p-coumaric acid, ferulic 
acid, p-hydroxybenzoic acid, and vanillic 
acid (mean contents 10.9, 52.3, 10.1, 9.6, 
5.4, and 18.2 µg/g, respectively), raffinose, 
stachyose, verbascose, and phytic acid (mean 
contents 8.5, 56.3, 5.5, and 11.5 mg/g, re-
spectively) (Díaz-Batalla et al., 2006). 
Besides its anti-obesity effect, it has been 
reported as a modulation of cardiovascular 
risk factors. For example, Zhu et al. (2012) 
reported that short-term feeding of a bean-
containing diet (30 and 60 %) reduced plas-
ma total cholesterol (1 and 16 %, respective-
ly) and LDL (21 and 37 %, respectively) 
levels without affecting HDL or total triglyc-
erides in diet-induced obese C57BL/6J mice. 
Similarly, Hernández-Saavedra et al. (2013b) 
reported that diet supplemented with 25 % 
cooked black P. vulgaris (N8025) flour in 
streptozotocin-induced diabetic rats signifi-
cantly reduced glucose (22.8 %), triglycer-
ides (21.9 %), total cholesterol (29.9 %) and 
LDL (56.1 %), correlating with a protection 
of pancreatic ß-cells compared with the dia-
betic control. 
Other research on anti-inflammatory ac-
tivity of P. vulgaris (two cultivars: Negro 
8025 and Pinto Durango) showed improved 
markers of inflammation in lipopolysaccha-
ride (LPS)-induced RAW 264.7 macrophag-
es (Oseguera-Toledo et al., 2011). They also 
reported that alcalase hydrolysates of com-
mon beans var. Pinto Durango at 120 min 
inhibited inflammation, with IC50 values of 
34.9, 13.9, 5.0, and 3.7 µM, while var. Negro 
8025 needed 43.6, 61.3, 14, and 48.2 µM for 
the inhibition of cyclooxygenase-2 expres-
sion, prostaglandin E2 production, eNOS 
expression and nitric oxide production, re-
spectively. In addition, the transactivation of 
NF-kB and nuclear translocation of the NF-
kB p65 subunit inhibition through hydroly-
sates was observed.  
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Capsicum annuum 
Capsicum species are used mostly as 
food; furthermore, a medicinal use was also 
reported, for example: as alternative of 
treatment for gastric ulcers, rheumatism, al-
opecia, and diabetes, among others (Tolan et 
al., 2004). Several studies have reported anti-
obesity activity by Capsicum annuum. Jeon 
et al. (2010) reported an anti-adipogenesis 
activity of methanol extract (doses 50, 100, 
and 200 μg/mL) from C. annuum seeds on 
adipocyte. They observed a lower lipid ac-
cumulation in these cells measured by color 
changes and compared with the control. Ad-
ditionally, methanol extracts of C. annuum 
seeds also down-regulated the expression of 
adipogenic trascriptor factors. Similar effects 
were observed on animal models. Kim and 
Park (2014) evaluated green pepper juice for 
its potential to reduce weight gain and to de-
termine its effects on lipid profiles in 
C57BL/6L mice fed at high-fat diet. Their 
results showed that mice fed at 45 % high-fat 
diet supplemented with green pepper juice 
(10 mL/kg/day) decreased 16 % their body 
weight gain compared with the obese con-
trols.  
On clinical trials, capsaicinoids from 
Capsicum were administrated to subjects 
(age 42 years and BMI 30.4) in dose of 6 
mg/day for 12 weeks, causing an abdominal 
adiposity reduction (21.1 %) than the place-
bo group (20.2 %), and this effect was posi-
tively correlated with the change in body 
weight. 
Among the anti-obesity mechanisms re-
ported for C. annuum, the effect on fat oxi-
dation was observed (Snitker et al., 2009); 
this is due to the stimulation of catechola-
mine secretion, promoting energy expendi-
ture, and reducing the accumulation of body 
fat mass (Powell, 2010). On the other hand, 
Baek et al. (2013) reported inhibitory effects 
of C. annuum water extracts on lipoprotein 
lipase activity in 3T3-L1 cells, decreasing 
the mRNA expression level to 50.9 % com-
pared with the control group. 
The chemical composition of C. annuum 
includes compounds such as capsaicin and 
several related capsaicinoids, cinnamic de-
rivatives, trigonelline, C4-substituted pyri-
dine, amino acids, small organic acids, and 
fatty acids (Ritota et al., 2010). Additionally, 
C. annum is considered a good source of vit-
amins C and E, provitamin A, carotenoids 
and various phenolics and flavonoids (Ma-
terska and Perucka, 2005). 
Besides its anti-obesity activity, C. annu-
um significantly decreased cardiovascular 
risk factors such as serum triglycerides 
(31 %), total cholesterol (12 %), and low 
density lipoproteins (36 %) in mice fed with 
a high-fat diet and supplemented with green 
pepper juice (10 mL/kg/day). Magied et al. 
(2014) reported that male albino rats contain-
ing 20 % high fat diet rendered diabetic with 
alloxan injection for 4 weeks and treated 
with 0.015 % capsaicin, decreased their 
blood serum glucose (50 %), serum choles-
terol (48 %), and serum triglycerides (69 %) 
compared with the diabetic control. 
 
Rosmarinus officinalis 
Rosemary (Rosmarinus officinalis L.) 
from the family Labiatae is an evergreen 
perennial shrub cultivated in many parts of 
the world and widely used as a spice, food 
supplement and for cosmetic applications 
(Aguilar et al., 2008; Harach et al., 2010). 
Traditionally, R. officinalis has been used in 
renal colic as an antispasmodic, to relieve 
dysmenorrheal symptoms (Takaki et al., 
2008) and respiratory disorders (Fabio et al., 
2007). 
Several studies report the effect of R. of-
ficinalis to promote weight loss. Harach et 
al. (2010) experimented with R. officinalis 
leaf extracts administered for 50 days at dos-
es to 200 mg/kg of body weight in mice fed a 
high-fat diet, which induced a significant re-
duction of weight and fat mass gain (64 and 
57 %, respectively). Similarly, Ibarra et al. 
(2011) reported that rosemary leaf extract 
standardized to 20 % carnosic acid was ad-
ministered (500 mg/kg body weight/day) in 
C57BL/6J mice fed with high-fat-diet, reduc-
ing body and epididymal fat (69 and 79 %, 
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respectively) compared with an obese con-
trol.  
The main anti-obesity activity reported 
for R. officinalis is that it increases fecal fat 
excretion without decreasing food intake 
(Harach et al., 2010; Ibarra et al., 2011). In 
concordance, Bustanji et al. (2010) reported 
an in vitro inhibitory effect of R. officinalis 
on hormone sensitive lipase and pancreatic 
lipase. The highest effect was for pancreatic 
lipase (IC50: 13.8 µg/mL) than hormone sen-
sitive lipase (IC50: 95.2 µg/mL), suggesting 
that extracts of R. officinalis had more affini-
ty for the first one. 
Another anti-obesity mechanism for R. 
officinalis is by its antiadipogenic activity. 
Gaya et al. (2013) reported that carnosic acid 
(5 μg/ml), the main bioactive compound of 
R. officinalis extract, inhibits 3T3-L1 preadi-
pocytes differentiation. This inhibition was 
accompanied by a blockade of mitotic clonal 
expansion. 
Besides carnosic acid, other compounds 
present in R. officinalis are monoterpenes, 
diterpenes and phenolics. The main polyphe-
nols identified are caffeic acid derivates such 
as rosmarinic acid (ester of caffeic acid and 
α-hydroxydihydrocaffeic acid) and α-
hydroxydihydrocaffeic acid, chlorogenic ac-
id, and their hydrolyzed metabolites (El 
Deeb, 1993; Herrero et al., 2010; Rababah et 
al., 2004; Wang et al., 2004).  
In addition to its anti-obese activity, 
rosemary leaf extracts standardized to 20 % 
carnosic acid in obese mice, also experienced 
72 % less in plasma glucose levels and 68 % 
less in total cholesterol compared with the 
control (Ibarra et al., 2011).  
On clinical trials, Labban et al. (2014) 
reported that 10 g/day of rosemary leaves 
powder for 4 weeks in men and women aged 
20 to 57 years, significantly reduced fasting 
serum glucose (18 %), total cholesterol 
(34 %), LDL concentration (34 %), triglycer-
ides (29 %), and malondialdehyde (36 %) 
compared with the baseline.  
These results suggest that rosemary is a 
good natural alternative for obesity and its 
metabolic alterations.  
Ilex paraguariensis 
Yerba mate (Ilex paraguariensis) is a na-
tive plant from the subtropical regions and 
one of the most consumed in South America. 
Its cultivation is done in Brazil, Argentina, 
Uruguay and Paraguay. Its leaves are used to 
prepare different beverages (Lima et al., 
2014a). Traditionally, they are used as mild 
central nervous system stimulant, diuretic, 
and in weight reducing preparations (Pang et 
al., 2008). 
Recently, I. paraguariensis has been 
studied due to its potential beneficial effects 
in the treatment of obesity. Kang et al. 
(2012) reported that treatment of I. para-
guariensis dried aqueous extract (2 g/kg of 
body weight) in C57BL/6J mice fed with 
high-fat diet affected food intake (-20 %), 
resulting in higher energy expenditure and 
losing body weight (23 %). Similarly, Lima 
et al. (2014a) reported that administration of 
an instant I. paraguariensis solution (1 g/kg 
body weight) once a day during 30 days by 
intragastric gavage in obese rats primed by 
early weaning, decreased their body weight 
(11 %) and food intake (25 %) compared 
with the control.  
The effect on food intake is considered 
the main anti-obesity mechanism of I. para-
guariensis. This improved the content of 
neuropeptide Y and may contribute to the 
correction of hyperphagia, independently of 
the leptin action (Seo et al., 2008).  
Focusing on the chemical composition, I. 
paraguariensis included flavonoids (quercer-
tin, rutin, and kaempferol) (Pomilio et al., 
2002), caffeoyl derivatives (caffeic acid, 
chlorogenic acid, 3, 4-dicaffeoylquinic acid, 
3, 5-dicaffeoylquinic acid, and 4, 5-
dicaffeoylquinic acid), methylxanthines (caf-
feine, theophylline, and theobromine), tan-
nins, and numerous triterpenic saponins that 
are derived from ursolic acid and are known 
as metesaponins (Andersen and Fogh, 2001; 
Pomilio et al., 2002). The polyphenol con-
tent in I. paraguariensis is higher than in 
green tea (Bixby et al., 2005). 
In vivo research showed that I. paraguar-
iensis has positive effects on metabolic alter-
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ations, consequence of obesity, including 
reductions in serum cholesterol, serum tri-
glycerides, and glucose concentrations. Kang 
et al. (2012) reported that treatment of obese 
mice with I. paraguariensis dried aqueous 
extracts, decreased the faster glucose (27 %) 
and total cholesterol (10 %) levels; whereas, 
Lima et al. (2014a) reported a reduction in 
serum triglycerides (31 %), faster glucose 
(12 %), and serum insulin (14 %) in obese 
rats treated with instant yerba mate solution. 
On the other hand, Lima et al. (2014b) 
reported that administration of I. pararguar-
iensis aqueous solution (1 g/kg body 
weight/day, gavage) for 30 days in obese rats 
primed by early weaning improved inflam-
matory profile (decreased TNF-α < 50 %, 
and increased IL-10 < 50 %) compared with 
their counterpart control. 
 
Citrus paradisi 
Grapefruit (Citrus paradisi) was first dis-
covered in the forests of Caribbean island, 
Barbados. It is now one of the widely culti-
vated fruits in the United States, particularly 
in Florida, California, and the other semi-
tropical Southern states. The fruit is a natural 
hybridization of pomelo and orange. The 
plant is a subtropical citrus tree and botani-
cally belongs to the large Rutaceae family of 
citrus fruits from the genus Citrus (Bailey, 
2004).  
Although, grapefruits are traditionally 
used for losing weight, there are only a few 
studies related to this activity. Gamboa-
Gómez et al. (2014) reported that treatment 
with C. paradisi infusion (ad lib.) on obese 
rats fed with a high-saturated-fat-diet exhib-
ited a reduction in adipocyte size and vol-
ume. These results were in agreement with 
triglycerides levels on adipose tissue, which 
were reduced in 16 % compared with obese 
controls. 
On the other hand, in a clinical trial, Fu-
jioka et al. (2006) reported an anti-obesity 
effect of grapefruit fresh, grapefruit juice and 
grapefruit capsules in obese patient with di-
agnosed metabolic syndrome. Ninety-one 
humans were included in 4 groups: placebo 
(placebo capsules and 207 mL of apple 
juice), group 2: (grapefruit capsules with 207 
mL of apple juice), group 3 (237 mL of 
grapefruit juice with placebo capsule), and 
group 4 (half of a fresh grapefruit with a pla-
cebo capsule) three times a day before each 
meal. After twelve weeks of treatment group 
4 had the highest effect decreasing 1.6 kg, 
followed by group 3, and group 2 with 1.5 
and 1.1 kg respectively. Similarly, Dow et al. 
(2012) reported that one half of a fresh Rio-
Red grapefruit with each meal (3Xdaily) for 
6 weeks was associated with modest weight 
loss (3 %) on overweight/obese subjects 
compared with control for 6 weeks. 
For the possible anti-obesity mechanism 
of C. paradisi Gamboa-Gómez et al. (2014) 
reported that C. paradisi infusion regulates 
the lipid metabolism, inducing relative ex-
pression of carnitine palmitoyl-transferase 1a 
(CPT1a) in obese rats compared with the 
control. CPT1a is responsible for the trans-
portation of long chain fatty acids into the 
mitochondria through binding to carnitine, 
and then moving into the route of β-
oxidation.  
Active compounds reported for C. para-
disi including flavonoids (naringin and hes-
peridin, lycopene, among others) and 
furanocoumarins (bergamottin and 6’,7’-
dihydroxybergamottin) (De Castro et al., 
2006; Gattuso et al., 2007), β-carotene, and 
d-limonene were also reported (Vanamala et 
al., 2005). 
Not only anti-obesity activity was report-
ed for C. paradisi, but also an improved ef-
fect on cardiovascular and diabetes risk fac-
tors. Gamboa-Gómez et al. (2014) reported 
that treatment with C. paradisi infusion im-
proved faster glucose concentration (28 %), 
insulin (37 %), and total triglycerides (26 %) 
in obese rats. The treatment with C. paradisi 
infusions improved, as well as hepatic oxida-
tive stress markers such as thiobarbituric ac-
id reactive substances (82 %) and carbonyl 
content of proteins (32 %) compared with 
the obese control.  
Same behavior was observed in clinical 
trials. Dow et al. (2012) reported improve-
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ments in circulating lipids in overweight 
adults that consumed grapefruit, with total 
cholesterol and LDL levels significantly de-
creasing, compared with baseline values. 
 
Citrus limon 
Lemon plant (Citrus limon L.) belongs to 
the Rutaceae family, and is the third most 
important Citrus species after orange and 
mandarin. Crude extracts of different parts of 
lemon (leaves, stem, root and flower) have 
anticancer activities and antibacterial poten-
tial against clinically significant bacterial 
strains (Kawaii et al., 2000). 
On obesity research, Fukuchi et al. 
(2008) reported that dietary lemon polyphe-
nols extracted from lemon peel (0.5 % w/w) 
on high-fat diet-induced obesity in 
C57BL/6J mice for 12 weeks suppressed 
body weight gain (44 %) and body fat accu-
mulation (36 %). 
One anti-obesity mechanism reported for 
lemon is by up-regulation of peroxisomal β-
oxidation through the increase mRNA level 
of acyl-CoA oxidase in the liver and white 
adipose tissues, which was likely mediated 
via up-regulation of the mRNA levels of per-
oxisome proliferator activated receptor-α 
(PPARα) (Fukuchi et al., 2008). 
Citrus limon contains many important 
phytochemicals, including phenolic com-
pounds (mainly flavonoids) and other nutri-
ents and non-nutrients (vitamins, minerals, 
dietary fiber, essential oils and carotenoids) 
(González-Molina et al., 2008). These com-
pounds are not equally distributed in the 
lemon fruit. Hesperidin and eriocitrin occur 
mainly in lemon juice; two isomers of hes-
peridin, neohesperidin and homoeriodictyol 
7-O-rutinoside have also been identified in 
lemon juices (González-Molina et al., 2008; 
Wang et al., 2008). Lemon seeds are rich in 
eriocitrin, hesperidin and in less amounts in 
naringin; whereas, the peel is rich in neoe-
riocitrin, neohesperidin and naringin and has 
minor amounts of narirutin (Baldi et al., 
1995). 
Additionally, it has been reported that C. 
limon has effects on metabolic alterations 
caused by obesity. Fukuchi et al. (2008), re-
ported that supplementation with lemon po-
lyphenols on high-fat diet-induced obesity in 
mice significantly improved hyperlipidemia 
(serum triglycerides -18 % , total cholesterol 
-26 %, and serum free fatty acids -5 %), hy-
perglycemia (insulin -65 % and faster glu-
cose -26 %), and insulin resistance (-75 %) 
than obese controls. 
Similarly, Naim et al. (2012) reported 
that hexane extracts from lemon peels 
showed antidiabetic activity in alloxan-
induced diabetic rats, detecting reduced 
blood glucose level of 44.57, 75.96, 95.43, 
and 98.08 % in 24, 48, 72, and 96 h, respec-
tively, compared with counterpart controls. 
Moreover, there are no reports on the an-
ti-obesity effect or its associated alterations 
of C. limon in clinical studies. 
 
Punica granatum 
Pomegranate (Punica granatum L.) is a 
small tree, belonging to the Punicaceae fami-
ly. Pomegranate, especially its fruit, possess-
es a vast ethnomedical history and represents 
a phytochemical reservoir of heuristic medic-
inal value (Lansky and Newman, 2007). Bio-
logical studies about pomegranate juice have 
shown antidiabetic effect (Katz et al., 2007). 
This activity is credited to the pomegranate’s 
high antioxidant capacity, which can be at-
tributed to its high content of polyphenols. 
On obesity research, Lei et al. (2007) re-
ported that treatment with pomegranate leaf 
extracts (400 and 800 mg/kg/day) for 5 
weeks in obese mice feed with a high-fat diet 
significantly decreased body weight (12 and 
20 %, respectively), energy intake (14 and 
30 %, respectively), and various adipose pad 
weight (14 and 42 %, respectively) than 
obese controls. 
Another study reported an anti-obesity 
effect of pomegranate seed oil in male 
C57BL/6J mice fed on a high-fat diet 
(1 g/100 g) for 12 weeks. Treatment de-
creased body weight (-10 %) and fat mass 
(50 %), whereas no differences in lean mass 
were observed. The latter compared with an 
untreated obese (Vroegrijk et al., 2011). 
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On the other hand, Xu et al. (2009) re-
ported that male Zucker diabetic fatty rats 
treated with pomegranate flower extract (500 
mg/kg) per 6 weeks, ameliorates diabetes 
and obesity-associated fatty liver, reducing 
ratio of liver weight to tibia length, hepatic 
triglyceride contents and lipid droplets.  
The anti-obesity mechanism reported for 
pomegranate flower is at least in part, by ac-
tivating hepatic expression of genes respon-
sible for fatty acid oxidation. Other anti-
obesity mechanisms reported for P. gran-
atum are inhibition of the pancreatic lipase 
activity, suppressing energy intake by appe-
tite suppressant (Lei et al., 2007).  
Pomegranate extracts (juice, seed oil, and 
flower extracts) are rich in many compounds 
such as proanthocyanidin flavonoids, and 
ellagitannins; additionally, several polysac-
charides, and many minerals including po-
tassium, nitrogen, calcium, magnesium, 
phosphorus, and sodium (Viuda-Martos et 
al., 2010). The pomegranate seeds contain 
high concentration of conjugated fatty acids 
such as linoleic and linolenic acids and other 
lipids: punicic acid, stearic acid, palmitic ac-
id, and phytosterols. Minor amounts of con-
jugated linolenic acid isomers including ele-
ostearic acid and catalpic acid, and phy-
tosterols are also found (Vroegrijk et al., 
2011). It has been identified tannins, antho-
cyanins, vitamin C, vitamin E, coenzyme 
Q10, and lipoic acid in pomegranate juice. 
Compounds such as anthocyanins, are re-
sponsible for the fruit color, being the most 
important phenolic group present in the arils 
or juice (Viuda-Martos et al., 2010). 
It has been reported that pomegranate ex-
tracts possess not only anti-obesity effect, 
but also action on the metabolic alterations 
associated to this disease. For example, Eidi 
(2014) reported that hydro-ethanolic extract 
of P. granatum flowers at 200 and 300 
mg/kg doses in streptozotocin-induced dia-
betic rats administered intraperitonally for 18 
days, significantly reduced the serum glu-
cose (37 % at both doses), cholesterol (14 % 
at both doses), triglycerides (33 and 16 %, 
respectively), LDL (50 % at both doses), 
urea (approx. 58 % at both doses), uric acid 
(40 % at both doses), creatinine (30 % at 
both doses), alanine amino transferase (ap-
prox. 27 % at both doses) and aspartate ami-
no transferase enzymes levels (approx. 27 % 
at both doses), while it increased serum HDL 
(14 %) level in comparison to control diabet-
ic rats. 
On clinical trials, Mirmiran et al. (2010) 
reported that consumption of pomegranate 
seed oil (400 mg) twice daily, for 4 weeks by 
hyperlipidaemic subjects, diagnosed accord-
ing to National Cholesterol Education Pro-
gram definition, decreased the total concen-
tration of serum triglycerides (20 %) com-
pared with baseline values. 
Moreover, more detailed molecular/cel-
lular studies in humans are needed to relate 
the anti-obesity potential of the fruit as 
common consumed by population. 
 
Aloe vera 
Aloe vera belongs to the family Liliace-
ae, and it is widely used in the manufactur-
ing of food and drink products, pharmaceuti-
cals, and cosmetics (Reynolds and Dweck, 
1999). Aloe species have been used around 
the world because of their antitumor, anti-
infection, anti-inflammatory, antioxidant, 
and laxative effects (Prabjone et al., 2006; 
Yu et al., 2009). 
Recent research studies have reported 
that Aloe vera has anti-obesity effect. Misa-
wa et al. (2012a) studied the effect of A. vera 
gel powder administration in Sprague-
Dawley rats with diet-induced obesity at two 
doses (20 and 200 mg/kg/day) for 90 days. 
They observed a modest decrease in body 
weight, but a significantly reduced subcuta-
neous (approx. 41 % at both doses) and vis-
ceral fat weight (16 and 30 %, respectively) 
compared with the obese control. 
Misawa et al. (2012b) reported that oral 
administration of lophenol and cycloartanol, 
two kinds of phytosterols isolated from A. 
vera (25 μg/kg/day) once a day for 44 con-
secutive days in Zucker diabetic fatty rats 
significantly reduced visceral fat weights 
(26 %) than obese control. 
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In clinical trials, Choi et al. (2010) re-
ported that treatment of pre-diabetes or early 
diabetes mellitus volunteers, with two cap-
sules (147 mg/capsule) of A. vera gel com-
plex after breakfast and two more after din-
ner for 8 weeks reduced body weight (2.5 %) 
and body mass fat (6.2 %) than the placebo 
group. Additionally, volunteers improved 
concentrations on fast glucose (2 %), insulin 
(8 %), and insulin resistance (11 %) com-
pared with baseline values. 
One proposed anti-obesity mechanism 
for A. vera is in part, by stimulation of ener-
gy expenditure (Misawa et al., 2012a). Other 
anti-obesity mechanism reported for A. vera 
is the regulation of expression levels of he-
patic genes encoding to lipogenic enzymes 
(ACC, FAS), and transcriptor factor SREBP-
1, which decreased significantly by the ad-
ministration of aloe sterols; and to the in-
creased of hepatic β-oxidation enzymes 
ACO, CPT1, PPARα (Misawa et al., 2012b). 
The chemical composition of A. vera in-
cludes components such as phytosterols, 
namely, lophenol, 24-methyllophenol, 24-
ethyllophenol, cycloartanol, and 24-methy-
lenecycloartanol, anthraquinones, carbohy-
drates, chromones, enzymes, inorganic com-
pounds, lipids, tannins, amino acids, pro-
teins, saccharides, vitamins, pectins, hemi-
celluloses, glucomannan, acemannan, and 
mannose derivatives (Misawa et al., 2012a). 
Several studies have shown beneficial ef-
fects of A. vera not only on obesity, but also 
on the associated metabolic disorders. For 
example, Mohamed (2011) reported that oral 
administration of A. vera gel extract (0.5 
mL/day for 6 weeks) in alloxan induced dia-
betic rats resulted in a significant reduction 
of serum glucose (52 %), total cholesterol 
(31 %), and triglycerides (20 %). The latter 
compared with an untreated diabetic control. 
On the other hand, the treatment with A. vera 
gel extract improved the oxidative stress 
condition evidenced by a significant decrease 
in serum malondialdehyde levels, a signifi-
cant increase in serum nitric oxide, and anti-
oxidant activity in treated diabetic group as 
compared with diabetic control group. 
Similarly, Huseini et al. (2012) reported 
that hyperlipidemic (hypercholesterolemic 
and/or hypertriglyceridemic) type 2 diabetic 
patients aged 40 to 60 not using other anti-
hyperlipidemic agents, have tried A. vera gel 
capsules (300 mg/12 h/ for 2 months), lower-
ing significantly their total cholesterol, LDL 
concentrations, blood glucose, and glycosyl-
ated hemoglobin (HbA1c) levels and no sig-
nificant effects in liver and kidney functions 
were noted compared with the control. 
 
Taraxacum officinale 
 Dandelion (Taraxacum officinale), is a 
member of the Asteraceae/Compositae fami-
ly. It has been considered as an herbal medi-
cine due to its antidiabetic, choleretic, and 
diuretic properties (Schütz et al., 2006). Sev-
eral studies reported that treatment with T. 
officinale could improve health, decreasing 
inflammation and tumors (Kim et al., 2007; 
Sigstedt et al., 2008).  
There is little information on the anti-
obesity effect of dandelion; however, just 
recently and despite not being the main ob-
jective, Davaatseren et al. (2013) found that 
T. officinale leaf extract (2 and 5 g/kg) on 
high-fat-diet-induced C57BL/6J mice re-
duced the body weight (12 and 7 %, respec-
tively) compared with the obese control.  
The main anti-obesity mechanism report-
ed for T. officinale was the inhibition in vitro 
and in vivo of pancreatic lipase (Zhang et al., 
2008); however, further studies are required 
leaving an open field to explore.  
The chemical characterization of T. offic-
inale includes luteolin-7-glucoside and apig-
enin-7-glucoside from leaf tissue (Wolbis 
and Krolikowska, 1985; Wolbis et al., 1993). 
Also, free quercetin and luteolin, luteolin-7 
and 4'-glucosides, luteolin-7-rutinoside, 
quercetin-7-glucoside and isorhamnetin-3-
glucoside and 3,7-diglucoside are present in 
combined leaf and flower extracts. Addition-
ally, caffeic acid was reported (Wolbis et al., 
1993), chlorogenic acids, and mono-
caffeyltartaric acid from the leaf, roots and 
flowers, and p-hydroxyphenylacetic acid 
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from both leaf and root tissues (Williams et 
al., 1996).  
Although, little information on body and 
fat weight effects is available, several studies 
report the effect of T. officinale on altera-
tions associated with obesity. For example, 
Choi et al. (2010) reported hypolipidemic 
effects of dandelion leaf (1 % w/w) in rabbits 
fed with a high-cholesterol diet. They report-
ed an improvement on lipid profile (-36 % 
on triglycerides, -11 % on LDL values, and 
29 % higher of HDL concentration) of treat-
ed rabbits compared with the control. Addi-
tionally, they reported an improvement on 
the thickness of aorta (58 % less than con-
trol). 
More recently, Davaatseren et al. (2013) 
reported that T. officinale leaf extract (2 and 
5 g/kg) on high-fat-diet-induced C57BL/6J 
mice improved faster glucose (approx. 
15 %), insulin (approx. 43 %), and insulin 
resistance (-49 %) than control. 
 
Arachis hypogaea 
Peanuts (Arachis hypogaea L.) belong to 
the Fabaceae family. Its cultivation is rele-
vant worldwide, being the fourth largest edi-
ble oilseed crop in the world (Shilman et al., 
2011). The primary use of peanuts is as food 
either as shelled nuts or as a source for seed 
oil. Peanut shells are considered as a non-
value contaminant residue, with thousands of 
tons produced annually by the peanut indus-
try (Sobolev and Cole, 2004). 
It has been reported that frequent nut 
consumption, including peanuts, was associ-
ated with a significantly lower risk of coro-
nary heart disease (Hu et al., 1998). 
On obesity research, Moreno et al. 
(2006) reported that ethanolic peanut shell 
extracts (1 % of extracts w/w, 85 days) re-
duced body weight (10 %) in high-fat diet 
male Wistar rats compared with the obese 
control. 
In a more recent study, Kang et al. 
(2014) studied the effect of high fat diets 
with low and high peanut sprout extract diets 
(20 % fat and 0.025 or 0.05 % peanut sprout 
extract) on Sprague-Dawley rats for 9 weeks, 
resulting in a decreasing body weight gain 
compared with the obese group. No statisti-
cal differences were reported for food con-
sumption between experimental groups. In 
addition, epididymal fat weight in high pea-
nut sprout extract group (3.61 g), or low 
peanut sprout extract group (3.80 g), was 
significantly lower than the control obese 
group (4.39 g). In the same experiment the 
authors found less total triglycerides (9.5 and 
12 % respectively) and total cholesterol (12 
and 13 %, respectively) than in the control 
group. 
Moreno et al. (2006) attributed the anti-
obesity effect of A. hypogaea to its inhibition 
of pancreatic lipase and other gastro-
intestinal lipases; they observed an increased 
fecal lipid content, decreasing the digestibil-
ity of dietary fat. Whereas Kang et al. (2014) 
attributed the anti-obesity activity of A. hy-
pogaea to the effect on expression of 
PPARγ. This is an adipogenic transcription 
factor, and the target gene adiponectin. They 
suggest that up-regulation of PPARγ and adi-
ponectin consequence of the consumption of 
peanut sprout extract in rats could be associ-
ated with the reported lower epidermal fat 
and total weight gain. Peanut shells (hulls, 
seed coats) contain several bioactive mole-
cules, such as luteolin, certain fatty acids, 
caffeic, ferulic and benzoic acids, all of 
which are able to inhibit lipases (Birari and 
Bhutani, 2007). Grosso and Guzman (1995) 
reported the following lipids on peanuts: 
Palmitic, stearic, oleic, linoleic, arachidic, 
eicosenoic, behenic, among others. The ster-
ol composition in peanut is β-sitosterol, 
campesterol, stigmasterol and Δ5 –avena-
sterol (Grosso et al., 2000). Besides the anti-
obesity effect of A. hypogaea, it has been 
reported with hypoglycemic, hypolipidemic, 
and hypertensive activities. Bilbis et al. 
(2002) reported that aqueous extract of A. 
hypogaea seeds (with free access to the ex-
tract as the only drinking water for 21 days) 
in normal and alloxan-induced diabetic rats 
decreased the fasting blood glucose level 
(189.0 to 107.55 mg/dL), and improved their 
lipid profile (14 % on total triglycerides, 
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11 % on total cholesterol, and 17 % in LDL 
concentration) compared with diabetic con-
trol.  
Similarly, Kang et al. (2014) found an 
improvement in lipid profile in rats fed with 
high fat diet using low and high peanut 
sprout extract diets (20 % fat plus 0.025 or 
0.05 % peanut sprout extract). 
On the other hand, Quist et al. (2009) re-
ported that raw and roasted peanut flour, pro-
teolytic digested, have an inhibitory effect on 
the activity of angiotensin converting en-
zyme (ACE) in vitro, exhibiting for alcalase 
digestion of raw peanut IC50 values of 8.7–
122 mg/mL, and from roasted flour 12–235 
mg/mL. More in vivo research is needed to 
expand on this effect. 
 
CONCLUSIONS 
Obesity is a significant and increasing 
public health problem worldwide. Even 
though, there are several treatments, such as 
surgery and drugs, there seems to be no effi-
cient treatment without potential side effects; 
thus, considering a lifestyle modification as 
the best option. In addition to a lifestyle 
modification, natural alternatives may pro-
vide increased health expectancy. As we 
have summarized, several plants possess an-
ti-obesity potential and have been poorly 
studied, while others are not even promoted.  
More anti-obesity data is needed, but in 
order to accomplish this, more research in this 
area with well-designed clinical trials fo-
cused on both safety and efficacy with some 
of these plants materials is required. 
 
Acknowledgements 
The authors gratefully acknowledge Bo-
gar M. Vallejo and tradu-c services for lan-
guage revision. 
 
REFERENCES 
Aguilar F, Autrup H, Barlow S, Castle L, Crebelli R, 
Dekant W, et al. Use of rosemary exracts as a food 
additive. Scientific opinion of the panel on food addi-
tives, flavourings, processing aids and materials in 
contact with food. EFSA J. 2008;721:1–29. 
Alarcon-Aguilar FJ, Zamilpa A, Perez-Garcia MD, 
Almanza-Perez JC, Romero-Nuñez E, Campos-Sepul-
veda EA, et al. Effect of Hibiscus sabdariffa on obesi-
ty in MSG mice. J Ethnopharmacol. 2007;114:66–71. 
Ali SAE, Mohamed AH, Mohammed GEE. Fatty acid 
composition, anti-inflammatory and analgesic activi-
ties of Hibiscus sabdariffa Linn. seeds. Adv Vet Anim 
Res. 2014;1:50–7. 
Andersen T, Fogh J. Weight loss and delayed gastric 
emptying following a South American herbal prepara-
tion in overweight patients. J Hum Nutr Diet. 2001; 
14:243-50. 
Antia BS, Okokon JE, Okon PA. Hypoglycemic ac-
tivity of aqueous leaf extract of Persea americana 
Mill. Indian J Pharmacol. 2005;37:325. 
Axling U, Olsson C, Xu J, Fernandez C, Larsson S, 
Ström K, et al. Green tea powder and Lactobacillus 
plantarum affect gut microbiota, lipid metabolism and 
inflammation in high-fat fed C57BL/6J mice. J Nutr 
Metab (Lond). 2012;9:105. 
Baek J, Lee J, Kim K, Kim T, Kim D, Kim C, et al. 
Inhibitory effects of Capsicum annuum L. water ex-
tracts on lipoprotein lipase activity in 3T3-L1 cells. 
Nutr Res Pract. 2013;7:96–102. 
Bailey GD, Malcolm J, Arnold O, Spence JD. Grape-
fruit juice-drug interactions. Brit J Clin Pharmacol. 
2004;58:S831–40. 
Baldi A, Rosen RT, Fukuda EK, Ho CT. Identifica-
tion of nonvolatile components in lemon peel by high-
performance liquid chromatography with confirma-
tion by mass spectrometry and diode-array detection. 
J Chromatogr. 1995;A718:89–97. 
Barnes PM, Powell-Griner E, McFann K, Nahin RL. 
Complementary and alternative medicine use among 
adults: United States, 2002. Adv Data. 2002;343:1–
19. 
Barquera S, Campos-Nonato I, Hernandez-Barrera L, 
Pedroza A, Rivera-Dommarco JA. Prevalencia de 
obesidad en adultos mexicanos, ENSANUT. 2012. 
Salud Pública de Mexico. 2013a;55:S151–60. 
EXCLI Journal 2015;14:809-831 – ISSN 1611-2156 
Received: February 11, 2015, accepted: June 16, 2015, published: July 09, 2015 
 
 
 
825 
Barquera S, Campos I, Rivera J. Mexico attempts to 
tackle obesity: the process, results, pushbacks and 
future challenges. Obes Rev. 2013b;14(Suppl 2):69–
78.  
Basu A, Sanchez K, Leyva MJ, Wu M, Betts NM, 
Aston CE, et al. Green tea supplementation affects 
body weight, lipids, and lipid peroxidation in obese 
subjects with metabolic syndrome. J Am Coll Nutr. 
2010;29:31–40. 
Berglund E, Vianna CR, Coppari R, Elmquist J. Di-
rect leptin action on POMC neurons regulates hepatic 
insulin sensitivity in mice. J Clin Inv. 2012;122:1000–
9. 
Bilbis LS, Shehu RA, Abubakar MG. Hypoglycemic 
and hypolipidemic effects of aqueous extract of Ara-
chis hypogaea in normal and Alloxan-induced diabet-
ic rats. Phytomedicine 2002;9:553–5. 
Birari R, Bhutani K. Pancreatic lipase inhibitors from 
natural sources:unexplored potential. Drug Discov 
Today. 2007;12:879–89. 
Bixby M, Spieler L, Menini T, Gugliucci A. Ilex par-
aguariensis extracts are potent inhibitors of nitrosative 
stress:A comparative study with green tea and wines 
using a protein nitration model and mammalian cell 
cytotoxicity. Life Sci. 2005;77:345–58. 
Boden G. Obesity, insulin resistance and free fatty 
acids. Curr Opin Endocrinol Diabetes Obes. 2011; 
18(2):139. 
Bose M, Lambert JD, Ju J, Reuhl KR, Shapses SA, 
Yang CS. The major green tea polyphenol, (-)-
epigallocatechin-3-gallate, inhibits obesity, metabolic 
syndrome, and fatty liver disease in high-fat-fed mice. 
J Nutr. 2008;138:1677–83. 
Brai BIC, Odetola AA, Agomo PU. Effects of Persea 
americana leaf extracts on body weight and liver li-
pids in rats fed hyperlipidaemic diet. Afr J Biotech. 
2007;6:1007–11. 
Bray GA. Medical consequences of obesity. J Clin 
Endocrinol Metab. 2004;89:2583–9. 
Broughton WJ, Hernandez G, Blair M, Beebe S, 
Gepts P, Vanderleyden J. Beans (Phaseolus spp.) 
model food legumes. Plant Soil. 2003;252:55–128. 
Bustanji Y, Issa A, Mohammad M, Hudaib M, Tawah 
K, Alkhatib H, et al. Inhibition of hormone sensitive 
lipase and pancreatic lipase by Rosmarinus officinalis 
extract and selected phenolic constituents. J Med 
Plants Res. 2010;4:2235–42. 
Cachofeiro V, Miana M, Martín-Fernández B, de las 
Heras N, Lahera V. Obesidad, inflamación y 
disfunción endotelial. Rev Esp Ob. 2006;4:195–204. 
Carai MA, Fantini N, Loi B, Colombo G, Gessa GL, 
Riva A, et al. Multiple cycles of repeated treatments 
with a Phaseolus vulgaris dry extract reduce food in-
take and body weight in obese rats. Brit J Nutr. 2011; 
106:762–8. 
Celleno L, Tolaini MV, D'Amore A, Perricone NV, 
Preuss HG. A dietary supplement containing stand-
ardized Phaseolus vulgaris extract influences body 
composition of overweight men and women. Int J 
Med Sci. 2007;4:45. 
Chang HC, Peng CH, Yeh DM, Kao ES, Wang CJ. 
Hibiscus sabdariffa extract inhibits obesity and fat 
accumulation, and improves liver steatosis in humans. 
Food Funct. 2014;5:734–9. 
Chaudhary N, Bhardwaj J, Seo HJ, Kim MY, Shin 
TS, Kim J D. Camellia sinensis fruit peel extract in-
hibits angiogenesis and ameliorates obesity induced 
by high-fat diet in rats. J Funct Foods. 2014;7:479–86. 
Choi UK, Lee OH, Yim JH, Cho CW, Rhee YK, Lim 
SI, et al. Hypolipidemic and antioxidant effects of 
dandelion (Taraxacum officinale) root and leaf on 
cholesterol-fed rabbits. Int J Mol Sci. 2010;11:67–78. 
Cunha CA, Lira FS, Rosa Neto JC, Pimentel GD, 
Souza GI, da Silva CMG, et al. Green tea extract sup-
plementation induces the lipolytic pathway, attenuates 
obesity, and reduces low-grade inflammation in mice 
fed a high-fat diet. Mediators Inflamm. 2013;2013:1–
8. 
Davaatseren M, Hur HJ, Yang HJ, Hwang JT, Park 
JH, Kim HJ et al. Taraxacum official (dandelion) leaf 
extract alleviates high-fat diet-induced nonalcoholic 
fatty liver. Food Chem Toxicol. 2013;58:30–6. 
De Castro WV, Mertens-Talcott S, Rubner A, Butter-
weck V, Derendorf H. Variation of flavonoids and 
furanocoumarins in grapefruit juices: A potential 
source of variability in grapefruit juice-drug interac-
tion studies. J Agric Food Chem. 2006;54:249–55.  
de Simone G, D'Addeo G. Sibutramine: balancing 
weight loss benefit and possible cardiovascular risk. 
Nutr Metab Cardiovasc Dis. 2008;18:337–41. 
Deng Y, Scherer PE. Adipokines as novel biomarkers 
and regulators of the metabolic syndrome. Ann NY 
Acad Sci. 2010;1212:E1–E19.  
EXCLI Journal 2015;14:809-831 – ISSN 1611-2156 
Received: February 11, 2015, accepted: June 16, 2015, published: July 09, 2015 
 
 
 
826 
Díaz-Batalla L, Widholm JM, Fahey GC, Castaño-
Tostado E, Paredes-López O. Chemical components 
with health implications in wild and cultivated Mexi-
can common bean seeds (Phaseolus vulgaris L). J 
Agric Food Chem. 2006;54:2045–52. 
Ding H, Chin YW, Kinghorn AD, D'Ambrosio SM. 
Chemopreventive characteristics of avocado fruit. 
Semin Cancer Biol. 2007;17:386–94. 
Dow CA, Going SB, Chow HHS, Patil BS, Thomson 
CA. The effects of daily consumption of grapefruit on 
body weight, lipids, and blood pressure in healthy, 
overweight adults. Metabolism. 2012;61:1026–35. 
Dulloo AG, Jacquet J, Solinas G, Montani JP, Schutz 
Y. Body composition phenotypes in pathways to obe-
sity and the metabolic syndrome. Int J Obes. 2010; 
34:S4–S17.  
Eidi M. Antidiabetic effect of Punica granatum L. 
hydro-ethanolic extract in streptozotocin-induced dia-
betic rats. Adv Biores. 2014;5:81–7. 
El Deeb KS. Investigation of tannin in some Labiatae 
species. Bull Faculty Pharmacol. 1993;31:237–41. 
Eringa EC, Stehouwer CD, van Nieuw Amerongen 
GP, Ouwehand L, Westerhof N, Sipkema P. Vasocon-
strictor effects of insulin in skeletal muscle arterioles 
are mediated by ERK1/2 activation in endothelium. 
Am J Physiol. 2004;287:H2043–8. 
Ester AVH, Soralys C, Rosa L, Coromoto GIL. 
Efecto del consumo de aguacate (Persea Americana 
Mill) sobre el perfil lipídico en adultos con 
dislipidemia. Anales Venez Nutr. 2009;2:84–9. 
Fabio A, Cermelli C, Fabio G, Nicoletti P, Quaglio P. 
Screening of the antibacterial effects of a variety of 
essential oils on microorganisms responsible for res-
piratory infections. Photother Res. 2007;21;374–7. 
Fonseca-Alaniz MH, Takada J, Alonso-Vale MI, 
Lima FB. Adipose tissue as an endocrine organ: From 
theory to practice. J Pediatr. 2007;83:S192–S203.  
Fujioka K, Greenway F, Sheard J, Ying Y. The effects 
of grapefruit on weight and insulin resistance: rela-
tionship to the metabolic syndrome. J Med Food. 
2006;9:49–54. 
Fukuchi Y, Hiramitsu M, Okada M, Hayashi S, Na-
beno Y, Osawa T, et al. Lemon polyphenols suppress 
diet-induced obesity by up-regulation of mRNA lev-
els of the enzymes involved in β-oxidation in mouse 
white adipose tissue. J Clin Biochem Nutr. 2008;43: 
201. 
Gamboa-Gómez C, Salgado LM, González-Gallardo 
A, Ramos-Gómez M, Loarca-Piña G, Reynoso-
Camacho R. Consumption of Ocimum sanctum L. and 
Citrus paradisi infusions modulates lipid metabolism 
and insulin resistance in obese rats. Food Funct. 
2014;5:927–35. 
Gattuso G, Barreca D, Gargiulli C, Leuzzi U, Caristi 
C. Flavonoid composition of citrus juices. Molecules. 
2007;12:1641–73. 
Gaya M, Repetto V, Toneatto J, Anesini C, Piwien-
Pilipuk G, Moreno S. Antiadipogenic effect of carno-
sic acid, a natural compound present in Rosmarinus 
officinalis is exerted through the C/EBPs and PPARγ 
pathways at the onset of the differentiation program. 
Biochim Biophys Acta. 2013;1830:3796–806. 
González-Molina E, Moreno DA, García-Viguera C. 
Genotype and harvest time influence the phytochemi-
cal quality of Fino lemon juice (Citrus limon (L.) 
Burm. F.) for industrial use. J Agric Food Chem. 
2008;56:1669–75. 
Goossens GH. The role of adipose tissue dysfunction 
in the pathogenesis of obesity-related insulin re-
sistance. Physiol Behav. 2008;94:206–18. 
Grosso NR, Guzman CA. Chemical composition of 
aboriginal peanut (Arachis hypogaea L.) seeds from 
Peru. J Agric Food Chem. 1995;43:102-5. 
Grosso NR, Nepote V, Guzmán CA. Chemical com-
position of some wild peanut species (Arachis L.) 
seeds. J Agric Food Chem. 2000;48:806–9. 
Grove KA, Sae‐Tan S, Kennett MJ, Lambert JD. Epi-
gallocatechin‐3‐gallate inhibits pancreatic lipase and 
reduces body weight gain in high fat‐fed obese mice. 
Obesity. 2012;20:2311–3. 
Grundy SM, Brewer HB, Cleeman JI, Smith SC, Len-
fant C. Definition of metabolic syndrome report of the 
National Heart, Lung, and Blood Institute/American 
Heart Association Conference on scientific issues 
related to definition. Circulation. 2004;109:433–8. 
Harach T, Aprikian O, Monnard I, Moulin J, Mem-
brez M, Beolor JC, et al. Rosemary (Rosmarinus of-
ficinalis L.) leaf extract limits weight gain and liver 
steatosis in mice fed a high-fat diet. Planta Med. 
2010;76:566–71. 
Hasani-Ranjbar S, Larijani B, Abdollahi M. A sys-
tematic review of the potential herbal sources of fu-
ture drugs effective in oxidant-related diseases. In-
flamm Allergy Drug Targ. 2009;8:2–10. 
EXCLI Journal 2015;14:809-831 – ISSN 1611-2156 
Received: February 11, 2015, accepted: June 16, 2015, published: July 09, 2015 
 
 
 
827 
Hasani-Ranjbar S, Nayebi N, Moradi L, Mehri A, 
Larijani B, Abdollahi M. The efficacy and safety of 
herbal medicines used in the treatment of hyper-
lipidemia;a systematic review. Curr Pharm Des. 2010; 
16:2935–47. 
Hasani-Ranjbar S, Jouyandeh Z, Abdollahi M. A sys-
tematic review of anti-obesity medicinal plants - an 
update. J Diabetes Metab Disord. 2013;12(1):28. 
Hernández-Saavedra D, Hernández-Montiel HL, 
Gamboa-Gómez CI, Salgado LM, Reynoso-Camacho 
R. The effect of Mexican herbal infusions on diet-
induced insulin resistance.  Nutrafoods. 2013a;12:55–
63. 
Hernández-Saavedra D, Mendoza-Sánchez M, Her-
nández-Montiel HL, Guzmán-Maldonado HS, Loar-
ca-Piña GF, Salgado LM, et al. Cooked common 
beans (Phaseolus vulgaris) protect against β-cell dam-
age in streptozotocin-induced diabetic rats. Plant 
Foods Hum Nutr. 2013b;68:207–12. 
Herrero M, Plaza M, Cifuentes A, Ibanez E. Green 
processes for the extraction of bioactives from Rose-
mary: Chemical and functional characterization via 
ultra-performance liquid chromatography-tandem 
mass spectrometry and in-vitro assays. J Chromatogr. 
2010;1217:2512–20. 
Hirosumi J, Tuncman G, Chang L, Görgün CZ, Uysal 
KT, Maeda K, et al. A central role for JNK in obesity 
and insulin resistance. Nature. 2002;420:333–6. 
Hu FB, Stampfer MJ, Manson JE, Rimm EB, Colditz 
GA, Rosner BA, et al. Frequent nut consumption and 
risk of coronary heart disease in women: prospective 
cohort study. BMJ. 1998;317:1341–5. 
Hursel R, Viechtbauer W, Dulloo AG, Tremblay A, 
Tappy L, Rumpler W, et al. The effects of catechin 
rich teas and caffeine on energy expenditure and fat 
oxidation: a meta-analysis. Obes Rev. 2011;12:e573– 
81. 
Husain GM, Chatterjee SS, Singh PN, Kumar V. Hy-
polipidemic and antiobesity-like activity of standard-
ised extract of Hypericum perforatum L. in rats. ISRN 
Pharmacology. 2011;2011:1–7. 
Huseini HF, Kianbakht S, Hajiaghaee R, Dabaghian 
FH. Anti-hyperglycemic and anti-hypercholesterol-
emic effects of Aloe vera leaf gel in hyperlipidemic 
type 2 diabetic patients:a randomized double-blind 
placebo-controlled clinical trial. Planta Med. 2012;78: 
311-6. 
Ibarra A, Cases J, Roller M, Chiralt-Boix A, Cous-
saert A, Ripoll C. Carnosic acid-rich rosemary (Ros-
marinus officinalis L.) leaf extract limits weight gain 
and improves cholesterol levels and glycaemia in 
mice on a high-fat diet. Brit J Nutr. 2011;106:1182–9. 
Jeon G, Choi Y, Lee SM, Kim Y, Jeong HS, Lee J. 
Anti-obesity activity of methanol extract from hot 
pepper (Capsicum annuum L.) seeds in 3T3-L1 adi-
pocyte. Food Sci Biotech. 2010;19:1123-7. 
Kahn SE, Hull RL, Utzschneider KM. Mechanisms 
linking obesity to insulin resistance and type 2 diabe-
tes. Nature. 2006;444:840–6. 
Kang YR, Lee HY, Kim JH, Moon DI, Seo MY, Park 
SH, et al. Anti-obesity and anti-diabetic effects of 
Yerba Mate (Ilex paraguariensis) in C57BL/6J mice 
fed a high-fat diet. Lab Anim Res. 2012;28:23–9. 
Kang NE, Ha AW, Woo HW, Kim WK. Peanut 
sprouts extract (Arachis hypogaea L.) has anti-obesity 
effects by controlling the protein expressions of 
PPARγ and adiponectin of adipose tissue in rats fed 
high-fat diet. Nutr Res Pract. 2014;8:158–64. 
Karamadoukis L, Shivashankar GH, Ludeman L, Wil-
liams AJ. An unusual complication of treatment with 
orlistat. Clin Nephrol. 2009;71:430-2. 
Katz SR, Newman RA, Lansky EP. Punica gran-
atum:heuristic treatment for diabetes mellitus. J Med 
Food. 2007;10:213–7. 
Kawaii S, Tomono Y, Katase E, Ogawa K, Yano M, 
Koizumi M, et al. Quantitative study of flavonoids in 
leaves of Citrus plants. J Agric Food Chem. 2000;48: 
3865–71. 
Kim MS, Kim JK, Kim HJ, Moon SR, Shin BCh, 
Park KW, et al. Hibiscus extract inhibits the lipid 
droplet accumulation and adipogenic transcription 
factors expression of 3T3-L1 preadipocytes. J Alt 
Compl Med. 2003;9:499–504. 
Kim J, Noh K, Cho M, Jang J, Song Y. Anti-
oxidative, anti-inflammatory and anti-atherogenic 
effects of dandelion (Taraxacum officinale) extracts in 
C57BL/6 mice fed atherogenic diet. FASEB J. 2007; 
21:862–7. 
Kim NH, Park SH. Evaluation of green pepper (Cap-
sicum annuum L.) juice on the weight gain and 
changes in lipid profile in C57BL/6 mice fed a high‐
fat diet. J Sci Food Agric. 2014;95:75–87. 
Labban L, Mustafa UES, Ibrahim YM. The effects of 
rosemary (Rosmarinus officinalis) leaves powder on 
glucose level, lipid profile and lipid perodoxation. Int 
J Clin Med. 2014;5:297–304. 
EXCLI Journal 2015;14:809-831 – ISSN 1611-2156 
Received: February 11, 2015, accepted: June 16, 2015, published: July 09, 2015 
 
 
 
828 
Lansky EP, Newman RA. Punica granatum (pome-
granate) and its potential for prevention and treatment 
of inflammation and cancer. J Ethnopharmacol. 2007; 
109:177–206. 
Lei F, Zhang XN, Wang W, Xing DM, Xie WD, Su 
H, et al. Evidence of anti-obesity effects of the pome-
granate leaf extract in high-fat diet induced obese 
mice. Int J Obes. 2007;3:1023–9. 
Levy BI, Ambrosio G, Pries AR, Struijker-Boudier 
HA. Microcirculation in hypertension:a new target for 
treatment? Circulation. 2001;104:735–40. 
Lima N, de Oliveira SE, da Silva APS, de 
Albuquerque Maia L, de Moura EG, Lisboa PC. Ef-
fects of Ilex paraguariensis (yerba mate) treatment on 
leptin resistance and inflammatory parameters in 
obese rats primed by early weaning. Life Sci. 
2014a;115:29–35. 
Lima NDS, Franco JG, Peixoto-Silva N, Maia LA, 
Kaezer A, Felzenszwalb I, et al. Ilex paraguariensis 
(yerba mate) improves endocrine and metabolic dis-
orders in obese rats primed by early weaning. Eur J 
Nutr. 2014b;53:73–82. 
Lu C, Zhu W, Shen CL, Gao W. Green tea polyphe-
nols reduce body weight in rats by modulating obesi-
ty-related genes. PloS One. 2012;7:e38332. 
Lubis AR, Widia F, Soegondo S, Setiawati A. The 
role of SOCS-3 protein in leptin resistance and obesi-
ty. Acta Med Indon. 2008;40:89–95. 
Magied MMA, Salama NAR, Ali MR. Hypoglycemic 
and hypocholesterolemia effects of intragastric ad-
ministration of dried red chili pepper (Capsicum an-
num) in alloxan-induced diabetic male albino rats fed 
with high-fat-diet. J Food Nutr Res. 2014;2:850–6. 
Malik VS, Willett WC, Hu FB. Global obesity: 
trends, risk factors and policy implications. Nat Rev 
Endocrinol. 2013;9:13–27. 
Materska M, Perucka I. Antioxidant activity of the 
main phenolic compounds isolated from hot pepper 
fruit (Capsicum annuum L.). J Agric Food Chem. 
2005;53:1750–6. 
Mather KJ, Lteif A, Steinberg HO, Baron AD. Inter-
actions between endothelin and nitric oxide in the 
regulation of vascular tone in obesity and diabetes. 
Diabetes. 2004;53:2060–6. 
Meigs JB, Larson MG Fox CS, Keaney JF Jr, Vasan 
RS, Benjamin EJ. Association of oxidative stress, 
insulin resistance, and diabetes risk phenotypes: the 
Framingham offspring study. Diabetes Care. 2007; 
30:2529–35. 
Mirmiran P, Fazeli MR, Asghari G, Shafiee A, Azizi 
F. Effect of pomegranate seed oil on hyperlipidaemic 
subjects:a double-blind placebo-controlled clinical 
trial. Brit J Nutr. 2010;104:402–6. 
Misawa E, Tanaka M, Nabeshima K, Nomaguchi K, 
Yamada M, Toida T, et al. Administration of dried 
Aloe vera gel powder reduced body fat mass in diet-
induced obesity (DIO) rats. J Nutr Sci Vitaminol. 
2012a;58:195–201. 
Misawa E, Tanaka M, Nomaguchi K, Nabeshima K, 
Yamada M, Toida T, et al. Oral ingestion of Aloe vera 
phytosterols alters hepatic gene expression profiles 
and ameliorates obesity-associated metabolic disor-
ders in zucker diabetic fatty rats. J Agric Food Chem. 
2012b;60:2799–806. 
Mohamed EAK. Antidiabetic, antihypercholestermic 
and antioxidative effect of Aloe vera gel extract in 
alloxan induced diabetic rats. Austral J Basic Appl 
Sci. 2011;5:1321–7. 
Montague CT, O’Rahilly S. The perils of portliness: 
causes and consequences of visceral adiposity. Diabe-
tes. 2000;49:883–8. 
Moon HS, Chung CS, Lee HG, Kim TG, Choi YJ, 
Cho CS. Inhibitory effect of (−)‐Epigallocatechin‐3‐
gallate on lipid accumulation of 3T3‐L1 cells. Obesi-
ty. 2007;15:2571-82. 
Moreno D, Ilic N, Poulev A, Raskin I. Effects of Ara-
chis hypogaea nutshell extract on lipid metabolic en-
zymes and obesity parameters. Life Sci. 2006;78: 
2797–803. 
Mracek T, Gao D, Tzanavari T, Bao Y, Xiao X, 
Stocker C, et al. Downregulation of zinc-α2-
glycoprotein in adipose tissue and liver of obese 
ob/ob mice and by tumor necrosis factor-α in adipo-
cytes. J Endocrinol. 2010;204:165–72. 
Muller WE. Effects of hypericum extract (Ll 160) in 
biochemical models of antidepressant activity. Phar-
macopsychiatry. 1997;30:102–7. 
Nahrstedt A, Butterweck V. Biologically active and 
other chemical constituents of the herb of Hypericum 
perforaturn L. Pharmacopsychiatry. 1997;30:129–34. 
Naim M, Amjad FM, Sultana S, Islam SN, Hossain 
MA, Begum R, et al. Comparative study of antidiabet-
ic activity of hexane-extract of lemon peel (Limon 
citrus) and glimepiride in alloxan-induced diabetic 
rats. Bangladesh Pharmac J. 2012;15:131–4. 
Naveh E, Werman MJ, Sabo E, Neeman I. Defatted 
avocado pulp reduces body weight and total hepatic 
fat but increases plasma cholesterol in male rats fed 
diets with cholesterol. J Nutr. 2002;132:2015–8. 
EXCLI Journal 2015;14:809-831 – ISSN 1611-2156 
Received: February 11, 2015, accepted: June 16, 2015, published: July 09, 2015 
 
 
 
829 
Newall CA, Anderson LA, Phillipson JD. Herbal 
medicines. A guide for health-care professionals. 
London: Pharmaceutical Press, 1996. 
Oseguera-Toledo ME, de Mejia EG, Dia VP, Amaya-
Llano SL. Common bean (Phaseolus vulgaris L.) hy-
drolysates inhibit inflammation in LPS-induced mac-
rophages through suppression of NF-κB pathways. 
Food Chem. 2011;127:1175–85. 
Padmanabhan M, Arumugam G. Effect of Persea 
americana (avocado) fruit extract on the level of ex-
pression of adiponectin and PPAR-γ in rats subjected 
to experimental hyperlipidemia and obesity. J Com-
plement Integr Med. 2014;11:107-19. 
Pang J, Choi Y, Park T. Ilex paraguariensis extract 
ameliorates obesity induced by high-fat diet:potential 
role of AMPK in the visceral adipose tissue. Arch 
Biochem Biophys. 2008;476:178–85. 
Park HJ, DiNatale DA, Chung MY, Park YK, Lee JY, 
Koo SI, et al. Green tea extract attenuates hepatic ste-
atosis by decreasing adipose lipogenesis and enhanc-
ing hepatic antioxidant defenses in ob/ob mice. J Nutr 
Biochem. 2011;22:393–400. 
Park HJ, Lee JY, Chung MY, Park YK, Bower AM, 
Koo SI, et al. Green tea extract suppresses NFκB acti-
vation and inflammatory responses in diet-induced 
obese rats with nonalcoholic steatohepatitis. J Nutr. 
2012:142:57–63. 
Peng CH, Chyau CC, Chan KC, Chan TH, Wang CJ, 
Huang CN. Hibiscus sabdariffa polyphenolic extract 
inhibits hyperglycemia, hyperlipidemia, and gly-
cation-oxidative stress while improving insulin re-
sistance. J Agric Food Chem. 2011;59:9901–9. 
Pomilio AB, Trajtemberg S, Vitale AA. High-perfor-
mance capillary electrophoresis analysis of mate infu-
sions prepared from stems and leaves of Ilex para-
guariensis using automated micellar electrokinetic 
capillary chromatography. Phytochem Anal. 2002;13; 
235–41. 
Poulain-Godefroy O, Lecoeur C, Pattou F, Frühbeck 
G, Froguel P. Inflammation is associated with a de-
crease of lipogenic factors in omental fat in women. 
Am J Physiol. 2008;295:R1–7. 
Powell SC. Red pepper as a probe for obesity. J Prot 
Res. 2010;9:2797. 
Prabjone R, Thong-Ngam D, Wisedopas N, Chatsu-
wan T, Patumraj S. Anti-inflammatory effects of Aloe 
vera on leukocyte endothelium interaction in the gas-
tric microcirculation of Helicobacter pylori-infected 
rats. Clin Hemorheol Microcircul. 2006;35:359−66. 
Quist EE, Phillips RD, Saalia FK. Angiotensin con-
verting enzyme inhibitory activity of proteolytic di-
gests of peanut (Arachis hypogaea L.) flour. LWT 
Food Sci Technol. 2009;42:694–9. 
Rababah TM, Hettiarachchy NS, Horax R. Total phe-
nolics and antioxidant activities of fenugreek, green 
tea, black tea, grape seed, ginger, rosemary, gotu kola, 
and ginkgo extracts, vitamin E, and tert-butylhydro-
quinone. J Agric Food Chem. 2004;52:5183–6. 
Reaven GM. Pathophysiology of insulin resistance in 
human disease. Physiol Rev. 1995;75:473–86. 
Reynolds T, Dweck AC. Aloe vera leaf gel: A review 
update. J Ethnopharmacol. 1999;68:3−37. 
Rieusset J, Bouzakri K, Chevillotte E, Ricard N, 
Jacquet D, Bastard JP, et al. Suppressor of cytokine 
signaling 3 expression and insulin resistance in skele-
tal muscle of obese and type 2 diabetic patients. Dia-
betes. 2004;53:2232–41. 
Ritota M, Marini F, Sequi P, Valentini M. Metabo-
lomic characterization of Italian sweet pepper (Capsi-
cum annum L.) by means of HRMAS-NMR spectros-
copy and multivariate analysis. J Agric Food Chem. 
2010;58:9675–84. 
Saltiel AR, Kahn CR. Insulin signaling and the regu-
lation of glucose and lipid metabolism. Nature. 
2001;414:799–806. 
Sánchez F, García R, Alarcón F, Cruz M. Adipocinas, 
tejido adiposo y su relación con células del sistema 
inmune. Gaceta Médica de México. 2005;141:505–
12.  
Schütz K, Carle R, Schieber A. Taraxacum – a review 
on its phytochemical and pharmacological profile. J 
Ethnopharmacol. 2006;107:313–23. 
Seo S, Ju S, Chung H, Lee D, Park S. Acute effects of 
glucagon-like peptide-1 on hypothalamic neuropep-
tide and AMP activated kinase expression in fasted 
rats. Endocrine J. 2008;55:867–74. 
Shamki AW, Ali A, Abdulaziz RS. Purification and 
characterization of amylase inhibitor extracted from 
white kidney bean (Phaseolus vulgaris). J Cell Plant 
Sci. 2012;3:17–21. 
Shilman F, Brand Y, Brand A, Hedvat I, Hovav R. 
Identification and molecular characterization of 
homeologous (Δ9-stearoyl acyl carrier protein desatu-
rase 3 genes from the allotetraploid peanut (Arachis 
hypogaea). Plant Mol Biol Rep. 2011;29:232–41. 
EXCLI Journal 2015;14:809-831 – ISSN 1611-2156 
Received: February 11, 2015, accepted: June 16, 2015, published: July 09, 2015 
 
 
 
830 
Sigstedt SC, Hooten CJ, Callewaert MC, Jenkins AR, 
Romero AE, Pullin MJ, et al. Evaluation of aqueous 
extracts of Taraxacum officinale on growth and inva-
sion of breast and prostate cancer cells. Int J Oncol. 
2008;32:1085–90. 
Skurk T, Alberti-Huber C, Herder C, Hauner H. Rela-
tionship between adipocyte size and adipokine ex-
pression and secretion. J Clin Endocrinol Metab. 
2007;92:1023–33. 
Slovacek L, Pavlik V, Slovackova B. The effect of 
sibutramine therapy on occurrence of depression 
symptoms among obese patients. Nutr Metab Cardio-
vasc Dis. 2008;18:e43-4. 
Snitker S, Fujishima Y, Shen H, Ott S, Pi-Sunyer X, 
Furuhata Y, et al. Effects of novel capsinoid treatment 
on fatness and energy metabolism in humans:possible 
pharmacogenetic implications. Am J Clin Nutr. 2009; 
89:45–50. 
Sobolev VS, Cole RJ. Note on utilization of peanut 
seed testa. J Sci Food Agric. 2004;84:105–11. 
Spadafranca A, Rinelli S, Riva A, Morazzoni P, Mag-
ni P, Bertoli S, et al. Phaseolus vulgaris extract affects 
glycometabolic and appetite control in healthy human 
subjects. Brit J Nutr. 2013;109:1789–95. 
Ståhlman M, Fagerberg B, Adiels M, Ekroos K, 
Chapman JM, Kontush A, et al. Dyslipidemia, but not 
hyperglycemia and insulin resistance is associated 
with marked alterations in the HDL lipidome in type 2 
diabetic subjects in the DIWA cohort: Impact on 
small HDL particles. BBA – Mol Cell Biol Lipids. 
2013:1831;1609–17. 
Takaki I, Bersani-Amado LE, Vendruscolo A, 
Sartoretto SM, Diniz SP, Bersani-Amado CA, et al. 
Anti-inflammatory and antinociceptive effects of 
Rosmarinus officinalis L. essential oil in experimental 
animal models. J Med Food. 2008;11:741–6. 
Thurairajah PH, Syn WK, Neil DA, Stell D, Haydon 
G. Orlistat (Xenical)-induced subacute liver failure. 
Eur J Gastroenterol Hepatol. 2005;7:1437–8. 
Tian C, Ye X, Zhang R, Long J, Ren W, Ding S, et al. 
Green tea polyphenols reduced fat deposits in high 
fat-fed rats via erk1/2-PPARγ-adiponectin pathway. 
PloS One. 2013;8:e53796.  
Tipoe GL, Leung TM, Hung MW, Fung ML. Green 
tea polyphenols as an anti-oxidant and anti-
inflammatory agent for cardiovascular protection. 
Cardiovasc Hematol Disord Drug Targets. 2007;7: 
135–44. 
Tolan I, Ragoobirsingh D, Morrison EYSA. Isolation 
and purification of the hypoglycaemic principle pre-
sent in Capsicum frutescens. Phytother Res. 2004; 
18:95–6. 
Tziomalos K, Krassas GE, Tzotzas T. The use of 
sibutramine in the management of obesity and related 
disorders:an update. Vasc Health Risk Manag. 2009; 
5:441.  
Vanamala J, Cobb G, Turner ND, Lupton JR, Yoo 
KS, Pike LM, et al. Bioactive compounds of grape-
fruit (Citrus paradisi Cv. Rio Red) respond differently 
to postharvest irradiation, storage, and freeze drying. J 
Agric Food Chem. 2005;53:3980–5. 
Viuda-Martos M, Fernandez-Lopez J, Perez-Alvarez 
JA. Pomegranate and its many functional components 
as related to human health:a review. Compr Rev Food 
Sci F. 2010;9:635–54. 
Vroegrijk IO, van Diepen JA, van den Berg S, West-
broek I, Keizer H, Gambelli L, et al. Pomegranate 
seed oil, a rich source of punicic acid, prevents diet-
induced obesity and insulin resistance in mice. Food 
Chem Toxicol. 2011;49:1426–30. 
Wang H, Provan GJ, Helliwell K. Determination of 
rosmarinic acid and caffeic acid in aromatic herbs by 
HPLC. Food Chem. 2004;87:307–11. 
Wang YC, Chuang YC, Hsu HW. The flavonoid, ca-
rotenoid and pectin content in peels of citrus cultivat-
ed in Taiwan. Food Chem. 2008;106:277–84. 
Williams CA, Goldstone F, Greenham J. Flavonoids, 
cinnamic acids and coumarins from the different tis-
sues and medicinal preparations of Taraxacum offici-
nale. Phytochemistry. 1996;42:121–7. 
Wolbis M, Krolikowska M. Polyphenolic compounds 
of dandelion (Taraxacum officinale). Acta Pol Pharm 
Drug Res. 1985;42:215–21. 
Wolbis M, Królikowska M, Bednarek P. Polyphenolic 
compounds in Taraxacum officinale. Acta Pol Pharm 
Drug Res. 1993;50:153–8. 
Wolfram S, Wang Y, Thielecke F. Anti‐obesity ef-
fects of green tea: From bedside to bench. Mol Nutr 
Food Res. 2006;50:176–87. 
Wree A, Mayer A, Westphal S, Beilfuss A, Canbay 
A, Schick RR, et al. Adipokine expression in brown 
and white adipocytes in response to hypoxia. J Endo-
crinol Inv. 2012;35:522–7. 
Xu KZY, Zhu C, Kim MS, Yamahara J, Li Y. Pome-
granate flower ameliorates fatty liver in an animal 
model of type 2 diabetes and obesity. J Ethnopharma-
col. 2009;123:280–7. 
EXCLI Journal 2015;14:809-831 – ISSN 1611-2156 
Received: February 11, 2015, accepted: June 16, 2015, published: July 09, 2015 
 
 
 
831 
Yasir M, Das S, Kharya MD. The phytochemical and 
pharmacological profile of Persea americana. Mill 
Pharmacog Rev. 2010;4:77. 
Ye J, Gao Z, Yin J, He Q. Hypoxia is a potential risk 
factor for chronic inflammation and adiponectin re-
duction in adipose tissue of ob/ob and dietary obese 
mice. Am J Physiol. 2007;293:E1118–28. 
Yegorova I, Jiang D. Compositions and methods for 
regulating metabolism and balancing body weight. US 
patent no. 6399089. 2002. 
Yu ZH, Jin C, Xin M, JianMin H. Effect of Aloe vera 
polysaccharides on immunity and antioxidant activi-
ties in oral ulcer animal models. Carbohyd Polymers. 
2009;75:307−11. 
Yuda N, Tanaka M, Suzuki M, Asano Y, Ochi H, 
Iwatsuki K. Polyphenols extracted from black tea 
(Camellia sinensis) residue by hot‐compressed water 
and their inhibitory effect on pancreatic lipase in 
vitro. J Food Sci. 2012;77:H254–61. 
Zhang J, Kang MJ, Kim MJ, Kim ME, Song JH, Lee 
YM, et al. Pancreatic lipase inhibitory activity of Ta-
raxacum officinale in vitro and in vivo. Nutr Res 
Pract. 2008;2:200–3. 
Zhu Z, Jiang W, Thompson HJ. Edible dry bean con-
sumption (Phaseolus vulgaris L.) modulates cardio-
vascular risk factors and diet-induced obesity in rats 
and mice. Brit J Nutr. 2012;108:S66–S73. 
